+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases

Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases

Antimicrobial Agents and ChemoTherapy 34(5): 858-862

Seven extended-spectrum beta-lactamases related to TEM and four enzymes derived from SHV-1 were transferred to a common Escherichia coli host so that the activity of a variety of beta-lactams could be tested in a uniform genetic environment. For most derivatives, penicillinase activity was 10% or less than that of strains making TEM-1, TEM-2, or SHV-1 beta-lactamase, suggesting that reduced catalytic efficiency accompanied the broader substrate spectrum. Despite this deficit, resistance to aztreonam, carumonam, cefdinir, cefepime, cefixime, cefmenoxime, cefotaxime, cefotiam, cefpirome, cefpodoxime, ceftazidime, ceftibuten, ceftizoxime, ceftriaxone, cefuroxime, and E1040 was enhanced. For strains producing TEM-type enzymes, however, MICs of carumonam, cefepime, cefmenoxime, cefotiam, cefpirome, and ceftibuten were 8 micrograms/ml or less. Susceptibilities of cefmetazole, cefotetan, cefoxitin, flomoxef, imipenem, meropenem, moxalactam, temocillin, FCE 22101, and Sch 34343 were unaffected. FCE 22101, imipenem, meropenem, and Sch 34343 were inhibitory for all strains at 1 microgram/ml or less. In E. coli an OmpF- porin mutation in combination with an extended-spectrum beta-lactamase enhanced resistance to many of these agents, but generally by only fourfold. Hyperproduction of chromosomal AmpC beta-lactamase increased resistance to 7-alpha-methoxy beta-lactams but not that to temocillin. When tested at 8 micrograms/ml, clavulanate was more potent than sulbactam or tazobactam in overcoming resistance to ampicillin, while cefoperazone-sulbactam was more active than ticarcillin-clavulanate or piperacillin-tazobactam, especially against TEM-type extended-spectrum beta-lactamases.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 039168800

Download citation: RISBibTeXText

PMID: 2193623

DOI: 10.1128/aac.34.5.858

Related references

Bactericidal activity of oral beta-lactam antibiotics in plasma and urine versus isogenic Escherichia coli strains producing broad- and extended-spectrum beta-lactamases. International Journal of Antimicrobial Agents 25(6): 479-487, 2005

Prevalence of the genes encoding extended-spectrum beta-lactamases, in Escherichia coli resistant to beta-lactam and non-beta-lactam antibiotics. Annals of Tropical Medicine and Parasitology 99(4): 413-417, 2005

Prevalence of gene(s) encoding extended spectrum beta lactamases (ESBL) in Escherichia coli resistant to beta lactam and non-beta lactam antibiotics. 2005

In vitro activity of beta-lactam and non-beta-lactam antibiotics in extended-spectrum beta-lactamase-producing clinical isolates of Escherichia coli. Diagnostic Microbiology and Infectious Disease 54(2): 135-139, 2006

Beta lactam antibiotics activity against escherichia coli omp f negative harboring extended spectrum beta lactamases. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 31: 117, 1991

Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases. Journal of Antimicrobial ChemoTherapy 46 Suppl A: 9, 2000

In vitro activities of parenteral beta-lactam antimicrobials against TEM-10-, TEM-26- and SHV-5-derived extended-spectrum beta-lactamases expressed in an isogenic Escherichia coli host. Journal of Antimicrobial ChemoTherapy 46(3): 461-464, 2000

An inoculum effect with beta-lactam antibiotics against enterobacteriaceae producing extended-spectrum beta-lactamases. Journal of Antimicrobial Chemotherapy 44(Suppl. A): 153, 1999

In vitro activity of meropenem and seven other beta-lactam antibiotics against K.pneumoniae and enterobacteriaceae producing beta-lactamases with extended spectrum. Pathologie-Biologie 42(5): 365-368, 1994

Exposure assessment of extended-spectrum beta-lactamases/AmpC beta-lactamases-producing Escherichia coli in meat in Denmark. Infection Ecology and Epidemiology 4:, 2014

Emergence of uropathogenic extended-spectrum beta lactamases-producing Escherichia coli strains in the community. Collegium Antropologicum 31(1): 227-233, 2007

Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamases. Journal of Clinical Microbiology 32(3): 691-696, 1994

Evaluation of six beta-lactam substrates for the detection of extended spectrum beta-lactamases producing Klebsiella pneumoniae strains from Brazil. Abstracts of the General Meeting of the American Society for Microbiology 97: 207, 1997

Extended-spectrum beta-lactamases (ESBL)/AmpC beta-lactamases-producing Escherichia coli in German fattening pig farms: a longitudinal study. Berliner und Munchener Tierarztliche Wochenschrift 127(9-10): 412-419, 2015

Diversity of Escherichia coli strains producing extended-spectrum beta-lactamases in Spain: second nationwide study. Journal of Clinical Microbiology 48(8): 2840-2845, 2010